Clinical Trial Update: A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Amicidin-β topical solution for surgical site and traumatic wound infections; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection
• Wound Infection

Drugs mentioned

• Amicidin-β topical solution (Amicidin-β)

Snippet

Sponsor: Macro Biologics, Inc. | Conditions: Surgical Wound Infection, Traumatic Wound Infection | Phase 1 | Status: RECRUITING